Why the study?
Dysregulated calcium handling impairs cardiac function and leads to cardiomyopathies, requiring methods to study myofilament-localized calcium signaling in dilated cardiomyopathy.
Describes a novel biosensor and analytical method to quantify calcium transients in hiPSC-CMs, enabling the phenotyping of dilated cardiomyopathy at the single-cell level.
Answers are grounded in this paper and cite their sources.
Supports hiPSC-CM phenotyping tools; leaves open clinical translation pending validation.
Synchronized contractions of cardiomyocytes within the heart are tightly coupled to electrical stimulation known as excitation-contraction coupling. Calcium plays a key role in this process and dysregulated calcium handling can significantly impair cardiac function and lead to the development of cardiomyopathies and heart failure. Here, we describe a method and analytical technique to study myofilament-localized calcium signaling using the intensity-based fluorescent biosensor, RGECO-TnT. Dilated cardiomyopathy is a heart muscle disease that negatively impacts the heart’s contractile function following dilatation of the left ventricle. We demonstrate how this biosensor can be used to characterize 2D hiPSC-CMs monolayers generated from a healthy control subject compared to two patients diagnosed with dilated cardiomyopathy. Lastly, we provide a step-by-step guide for single-cell data analysis and describe a custom Transient Analysis application, specifically designed to quantify features of calcium transients. All in all, we explain how this analytical approach can be applied to phenotype hiPSC-CM behaviours and stratify patient responses to identify perturbations in calcium signaling.
No takes yet. Share an insight, caveat, or question.
Hawey et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: